Susie Miller

Susie Miller supports the National Institute of Allergy and Infectious Diseases (NIAID) in executing critical procurement activities aligned with its mission to advance biomedical countermeasures against infectious, immunologic, and allergic threats. Though her official title is not publicly designated, she plays a pivotal role in managing contract actions for high-containment laboratory services and specialized biosafety infrastructure. Her work directly enables NIAID’s strategic priorities by securing technical and operational support essential for research in biosafety level 3 and 4 environments, including diagnostic development, pathogen handling, and biocontainment system maintenance. She primarily handles service-based acquisitions under the NAICS 811219 category, focusing on scientific and medical laboratory services that underpin public health preparedness. Miller’s procurement portfolio is heavily concentrated with Quality Biological, Inc., a leading provider of biological reference materials and high-containment laboratory support services based in Gaithersburg, MD. Her working relationships reflect a preference for established, technically specialized vendors with proven expertise in handling infectious agents and maintaining federal biosafety compliance. These partnerships are characterized by long-term, performance-driven contracts requiring stringent regulatory adherence and scientific rigor, rather than broad competitive bidding. Miller’s contracting patterns show no use of socioeconomic set-asides, with 100% of awards issued under full and open competition. This reflects NIAID’s operational need for highly specialized capabilities that are currently available only through a limited pool of qualified providers, rather than a policy preference against small business participation. Her approach prioritizes technical fitness and regulatory compliance over socioeconomic criteria. Her primary procurement focus is NAICS 811219—Other Scientific and Technical Consulting Services—encompassing advanced laboratory operations, pathogen characterization, and biocontainment support. She procures services critical to infectious disease research, including specimen processing, high-containment animal studies, and diagnostic assay validation, demonstrating deep domain expertise in biosafety and biomedical research infrastructure.